SMV
Sofinnova Management VIII Portfolio holdings
AUM
$183M
1-Year Est. Return
4.18%
This Fund
S&P 500
1 Year Est. Return
+4.18%
AUM
$164M
AUM Growth
-$14.4M
(-8.1%)
Holding
10
Top Sells
| 1 | +$27.3M | |
| 2 | +$16.1M | |
| 3 | +$4.79M | |
| 4 |
SYBX
Synlogic
SYBX
|
+$205 |
Sector Composition
| 1 | Healthcare | 73.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
1
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $42.9M | 26.16% |
481,270
-211,858
|
|
||
2
Aclaris Therapeutics
ACRS
$426M
| $39.7M | 24.23% |
1,539,480
|
|
||
|
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $30.5M | 18.61% |
3,749,623
|
|
||
4
Natera
NTRA
$27.8B
| $20M | 12.18% |
1,550,280
|
|
||
|
NCNA
5
NuCana
NCNA
$6.16M
| $12.2M | 7.47% |
+133
|
|
||
|
SYBX
6
DELISTED
Synlogic
SYBX
| $8.08M | 4.93% |
28,331
-1
|
|
||
|
CYTO
7
DELISTED
Altamira Therapeutics Ltd
CYTO
| $6.41M | 3.91% |
98
|
|
||
8
Ocugen
OCGN
$643M
| $4.11M | 2.51% |
34,617
|
|
||
|
ARAV
9
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
-260,543
|
|
||
|
INNL
10
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| – | – |
-2,103,173
|
|